Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance – Business Wire (press release)
|
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Business Wire (press release) LENEXA, Kan.–(BUSINESS WIRE)–Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a group of the top 30 companies developing cancer immunotherapy … |
